Medical device sponsors are diversifying study formats, from launching decentralized protocols to relying more on real-world evidence. They are increasingly using electronic patient-reported outcome (ePRO) tools like apps and web-based solutions. A survey by Medrio and studioID reveals that more than 90% of respondents view ePRO tools as valuable resources for medical device trials. However, barriers hinder widespread adoption.
This report presents the 2023 survey findings, and offers insights from Medrio experts. It explores the challenges, opportunities, and trends surrounding patient-reported outcomes in a changing research landscape, encouraging a more intentional approach.